Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 146 | 175 | 668 | 692 | 402 |
| Operating Income | -146 | -175 | -668 | -692 | -402 |
| Other Income | 1 | -55 | 178 | 179 | 12 |
| Pre-tax Income | -145 | -230 | -490 | -513 | -391 |
| Net Income Continuous | -145 | -230 | -490 | -513 | -391 |
| Net Income | $-145 | $-230 | $-490 | $-513 | $-391 |
| EPS Basic Total Ops | -0.15 | -0.15 | -0.15 | N/A | 0.00 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.06 | -0.07 | -0.06 |
| EPS Diluted Total Ops | -0.15 | -0.15 | -0.15 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.06 | -0.07 | -0.06 |
| EBITDA(a) | $-100 | $-174 | $-667 | $-689 | $-402 |